Minghui Pharmaceutical
Shanghai, China · Founded 2018 · $131.0M raised
- Headquarters
- Shanghai
- Employees
- 11–50
- Founded
- 2018
- Business Model
- B2B
- Website
- minghuipharma.com
- Total Funding
- $131.0M
- Last Round
- $131.0M Venture RoundAug 2025
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Minghui Pharmaceutical is a Shanghai-based, late-stage clinical biopharmaceutical company developing innovative medicines for oncology and immunology. Its pipeline includes a topical JAK inhibitor under NDA review in China, a subcutaneous IGF-1R antibody in Phase 3 trials for thyroid eye disease, and a PD-1/VEGF bispecific antibody in Phase 2 trials. The company raised $131M in Pre-IPO financing in 2025 led by OrbiMed and Qiming Venture Partners.
Summary
Minghui Pharmaceutical is a Biotech company based in Shanghai, China, founded in 2018. It has raised $131.0M in total across 1 round, most recently a $131.0M Venture Round in Aug 2025. Investors include OrbiMed, Qiming VP and TF Capital.
Funding History
Aug 2025
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/minghui-pharmaceutical"><img src="https://indexed.vc/api/badge/company/minghui-pharmaceutical" alt="Minghui Pharmaceutical on Indexed.vc" width="260" height="76" /></a>